The pharmaceutical landscape is experiencing a shift with the introduction of GLP-1 transdermal systems . These cutting-edge formulations offer a potential alternative to providing glucagon-like peptide-1 https://adamtuoz482954.dreamyblogs.com/41246549/glp-1-patches-a-novel-way-to-treat-diabetes